Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tirofiban before endovascular thrombectomy in acute ischemic stroke
ChiCTR2500113387Phase 3Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Tirofiban group with Placebo group (2 arms). Primary endpoint: Proportion of patients with mRS 0–2 at 90 days. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2500113387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113387.